Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events: Lipoproteins and Coronary Atherosclerosis Study

Atherosclerosis

Volumn 144, Issue 2, 1999, Pages 435-442

  Sing, Karandeep ^a   Ballantyne, Christie M ^a   Ferlic, Laura ^a   Brugada, Ramon ^a   Cushman, Ian ^a   Dunn, J Kay ^a   Herd, J Alan ^a   Pownall, Henry J ^a   Gotto, Antonio M ^a   Marian, Ali J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Genetics; Lipoprotein lipase; Mutation; Myocardial infarction; Risk factor

Indexed keywords

CHOLESTEROL; FLUINDOSTATIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR LESION;

ADULT; AGED; AMINO ACIDS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; FATTY ACIDS, MONOUNSATURATED; FEMALE; GENOTYPE; HUMANS; INDOLES; LIPIDS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0033016308     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00004-0     Document Type: Article

References (38)

1. American Heart Association Heart and Stroke Facts: http://www.americanheart.org/Heart_and_Stroke_A-Z_Guide/has.html.
2. Slack J., Evans K.A. The increased risk of death from ischemic heart disease in first degree relatives of 121 men and 96 women with ischemic heart disease. J. Med. Genet. 3:1966;239-257.
3. Jorde L.B., Williams R.R. Relation between family history of coronary artery disease and coronary risk variables. Am. J. Cardiol. 62:1988;708-713.
4. Chamberlain J.C., Galton D.J. Genetic susceptibility to atherosclerosis. Br. Med. Bull. 46:1990;917-940.
5. Marenberg M.E., Risch N., Berkman L.D., Floderus B., deFaire U. Genetic susceptibility to death from coronary artery disease in a study of twins. N. Engl. J. Med. 330:1994;1041-1046.
6. Duffy D.L., O'Connell D.L., Heller R.F., Martin N.G. Risk factors for atherosclerosis in twins. Genet. Epidemiol. 10:1993;557-562.
7. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
8. Ghosh S., Collins F.S. The geneticist's approach to complex disease. Annu. Rev. Med. 47:1996;333-353.
9. Marian A.J. Genetic risk factors for myocardial infarction. Curr. Opin. Cardiol. 13:1998;171-178.
10. Marian A.J. Genetic markers: genes involved in atherosclerosis. J. Cardiovasc. Risk. 4:1997;333-339.
11. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N. Engl. J. Med. 325:1991;373-381.
12. Brenn T. Genetic and environmental effects on coronary heart disease risk factors in northern Norway. The cardiovascular disease study in Finnmark. Ann. Hum. Genet. 58:1994;369-379.
13. Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 323:1989;1060-1068.
14. Sparkes R.S., Zollman S., Klisak I., Kirshgessner T.G., Komaromy M.C., Mohandas T., Schotz M.C., Lusis A.J. Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics. 1:1987;138-144.
15. Nickerson D.A., Taylor S.L., Weiss K.M., Clark A.G., Hutchinson R.G., Stengard J., Salomaa V., Vartiainen E., Boerwinkle E., Sing C.F. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat. Genet. 19:1998;233-240.
16. Weinstock P.H., Bisgaier C.L., Aalto-Setala, Radner H., Ramakrishnan R., Levak-Frank S., Essenburg A.D., Zechner R., Breslow J.L. Severe hypertriglyceridimia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96:1995;2555-2568.
17. Heinzmann C., Ladias J., Antonarakis S., Kirchgessner T., Schotz M., Lusis A.J. RFLP for the human lipoprotein-lipase (LPL) gene: HindIII. Nucleic Acids Res. 15:1987;6763.
18. Li S., Oka K., Galton D., Stocks J. Pvu-II RFLP at the human lipoprotein lipase gene locus. Nucleic Acids Res. 16:1988;2358.
19. Chamberlain J.C., Thorn J.A., Oka K., Galton D.J., Stokes J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 79:1989;85-91.
20. Thorn J.A., Chamberlain J.C., Alcolado J.C., Oka K., Chan L., Stokes J., Galton D.J. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis. 85:1990;55-60.
21. Heizmann C., Kirchgessner T., Kwiterovich P.O., Ladias J.A., Derby C., Antonarakis S.E., Schotz M.C., Lusis A.J. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum. Genet. 86:1991;578-584.
22. Ahn Y.I., Kamboh M.I., Hamman R.F., Cole S.A., Ferrell R.E. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J. Lipid Res. 34:1993;421-428.
23. Gerdes C., Gerdes L.U., Hansen P.S., Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation. 92:1995;1765-1769.
24. 9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 1996;94:1913-1918.
25. Wang X.L., McCredie R.M., Wilcken D.E.L. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation. 93:1996;1339-1345.
26. Mailly F., Fisher R.M., Nicaud V., Luong L.-A., Evans A.K., MarquesVidal P., Luc G., Arveiler D., Bard J.M., Poirier O., Talmud P.J., Humphries S.E. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis. 122:1996;21-28.
27. Nordestgaard B.G., Abildgaard S., Wittrup H.H., Steffensen R., Jensen G., Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 96:1997;1737-1744.
28. Mattu R.K., Needham E.W.A., Morgan R., Rees A., Hackshaw A.K., Stokes J., Elwood P.C., Galton D.J. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler. Thromb. 14:1994;1090-1097.
29. Jemaa R., Fumeron F., Poirier O., Lecerf L., Evans A., Arveiler D., Luc G., Cambou J.-P., Bard J.-M., Fruchart J.-C., Apfelbaum M., Cambein F., Tiret L. Lipoprotein lipase gene polymorphism: associations with myocardial infraction and lipoprotein levels, the ECTIM study. J. Lipid Res. 36:1995;2141-2146.
30. Reymer P.W.A., Gagne E., Groenemeyer B.E., Zhang H., Forsyth I., Jansen H., Seidell J.C., Kromhout D., Lie K.E., Kastelein J., Hayden M.R. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10:1995;28-34.
31. Wittrup H.H., Tybjærg-Hansen, Abildgaard S., Steffensen R., Schnohr P., Nordestgaard B.G. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J. Clin. Invest. 99:1997;1606-1613.
32. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, Faergeman O, on behalf of the EARS Group. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentration. Studies in fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 1997;96:733-740.
33. Groenemeijer BE, Hallman MD, Reymer PW, Gagne E, Kuivenhoven JA, Bruin T, Jansen H, Lie KI, Bruschke AV, Boerwinkle E, Hayden MR, Kastelein JJ for the REGRESS study group. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. Circulation 1997; 95: 2628-2635.
34. Wittekoek M.E., Pimstone S.N., Reymer P.W.A., Feuth L., Botma G.-J., Defesche J.C., Prins M., Hayden M.R., Kastelein J.J.P. A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia. Circulation. 97:1998;729-735.
35. Herd A.J., West M.S., Ballantyne C., Farmer J., Gotto A.M. Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatin. Am. J. Cardiol. 73:1994;42D-49D.
36. Herd JA, Ballantyne CM, Farmer JA, Ferguson III JJ, Jones PH, West MS, Gould KL, Gotto AM Jr for the LCAS Investigators. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol 1997;80:278-286.
37. Reiber J.H.C., Serruys P.W., Kooijman C.J., Wijns W., Slager C.J., Gerbrands J., Schuurbiers J.C.H., den Boer A., Hugenholtz P.G. Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 71:1985;280-288.
38. Miller S.A., Dykes D.D., Polesky H.F. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.